home new2022-10-13T14:54:37-07:00
[rev_slider alias=”slider-3″ /]

Featured Articles

PLEOPHARMA TO PRESENT NEWDATA ON CANNABIS WITHDRAWAL In PATIENTS WITH CANNABIS USE DISORDER AND PHASE 2 PP-01 RESULTS AT THE COLLEGE ON PROBLEMS OF DRUG DEPENDENCE 88TH ANNUAL SCIENTIFIC MEETING

Presentations will highlight the patient experience of cannabis withdrawal/cannabis use disorder and Phase 2 CAN-002 data for investigational PP-01 in adults with cannabis use disorder PHOENIXVILLE, Pa., June 15, 2026 /PRNewswire/ -- PleoPharma, a clinical-stage clinical development company focused on cannabis-related health issues, announced today that it will present two posters...

HUD Secretary: Regulatory Environment Hindering Housing

Housing and Urban Development (HUD) Secretary Scott Turner recently stressed that the Trump Administration has been intentional about tearing down the regulatory environment that many have blamed as a cause for housing affordability across America. Appearing on CNBC, the conversation focused on regulatory burdens that officials say add roughly $100,000...

Featured STOCK

 
Go to Top